Inventor
LABELLE MARC
CA43 patents
⚠️ This page may combine multiple inventors who share the name “LABELLE MARC”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MERCK FROSST CANADA INC
16 patentsUS5532237AJul 2, 1996
Indole derivatives with affinity for the cannabinoid receptor
MERCK FROSST CANADA INC223 citations99
US5565473AOct 15, 1996
Unsaturated hydroxyalkylquinoline acids as leukotriene antagonists
MERCK FROSST CANADA INC156 citations97
US5270324ADec 14, 1993
Fluorinated hydroxyalkylquinoline acids as leukotriene antagonists
MERCK FROSST CANADA INC54 citations96
US6410583B1Jun 25, 2002
Cyclopentanoindoles, compositions containing such compounds and methods of treatment
MERCK FROSST CANADA INC63 citations95
US6211197B1Apr 3, 2001
Prostaglandin receptor ligands
MERCK FROSST CANADA INC61 citations94
US5856322AJan 5, 1999
Unsaturated hydroxyalkylquinoline acids as leukotriene antagonists
MERCK FROSST CANADA INC36 citations92
US5798442AAug 25, 1998
Peptidyl derivatives as inhibitors of pro-apoptotic cysteine proteinases
MERCK FROSST CANADA INC25 citations92
US5428033AJun 27, 1995
Saturated hydroxyalkylquinoline acids as leukotriene antagonists
MERCK FROSST CANADA INC42 citations92
US5266568ANov 30, 1993
Hydroxyalkylquinoline ether acids as leukotriene antagonists
MERCK FROSST CANADA INC29 citations92
US6242493B1Jun 5, 2001
Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment
MERCK FROSST CANADA INC41 citations91
US6369084B1Apr 9, 2002
Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment
MERCK FROSST CANADA INC15 citations84
US6436965B1Aug 20, 2002
PDE IV inhibiting amides, compositions and methods of treatment
MERCK FROSST CANADA INC17 citations83
US5472964ADec 5, 1995
Diaryl 5,6-fused heterocyclic acids as leukotriene antagonists
MERCK FROSST CANADA INC20 citations83
US6369082B1Apr 9, 2002
Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment
MERCK FROSST CANADA INC12 citations73
US6414006B1Jul 2, 2002
Methods for inhibiting bone resorption
MERCK FROSST CANADA INC12 citations72
US6277839B1Aug 21, 2001
Biphenylene lactams as prostaglandin receptor ligands
MERCK FROSST CANADA INC4 citations62
AMGEN INC
6 patentsUS7199119B2Apr 3, 2007
Antiinflammation agents
AMGEN INC75 citations95
US7635695B2Dec 22, 2009
Antiinflammation agents
AMGEN INC10 citations82
US6846834B2Jan 25, 2005
Antiinflammation agents
AMGEN INC15 citations82
US7402704B2Jul 22, 2008
Arylsulfones and uses related thereto
AMGEN INC3 citations62
US7754890B2Jul 13, 2010
Arylsulfones and uses related thereto
AMGEN INC0 citations51
US7176314B2Feb 13, 2007
Inflammation modulators
AMGEN INC0 citations39
GILEAD SCIENCES INC
4 patentsUS9650339B2May 16, 2017
Inhibitors of histone demethylases
GILEAD SCIENCES INC2 citations70
US10221139B2Mar 5, 2019
Inhibitors of histone demethylases
GILEAD SCIENCES INC0 citations51
US10189787B2Jan 29, 2019
Inhibitors of histone demethylases
GILEAD SCIENCES INC0 citations51
US9802941B2Oct 31, 2017
Compounds and methods for inhibiting histone demethylases
GILEAD SCIENCES INC0 citations36
NMD PHARMA AS
3 patentsUS11730714B2Aug 22, 2023
Compounds for the treatment of neuromuscular disorders
NMD PHARMA AS2 citations65
US11147788B2Oct 19, 2021
Compounds for the treatment of neuromuscular disorders
NMD PHARMA AS2 citations64
US10934244B2Mar 2, 2021
Compounds for use in treating neuromuscular disorders
NMD PHARMA AS4 citations60